DPI-221
|
(IUPAC) ime
|
4-((αS)-α-((2S,5R)-2,5-dimetil-4-(3-fluorobenzil)-1-piperazinil)benzil)-N,N-dietilbenzamid
|
Klinički podaci
|
Identifikatori
|
ATC kod
|
?
|
PubChem[1][2]
|
9891642
|
Hemijski podaci
|
Formula
|
C21H38FN3O
|
Mol. masa
|
487,65 g/mol
|
SMILES
|
eMolekuli & PubHem
|
InChI |
InChI=1S/C31H38FN3O/c1-5-33(6-2)31(36)28-17-15-27(16-18-28)30(26-12-8-7-9-13-26)35-21-23(3)34(20-24(35)4)22-25-11-10-14-29(32)19-25/h7-19,23-24,30H,5-6,20-22H2,1-4H3 Y Key: KEXJLZMJVOTFOY-UHFFFAOYSA-N Y |
|
Farmakoinformacioni podaci
|
Trudnoća
|
?
|
Pravni status
|
|
DPI-221 je lek koji se koristi u naučnim istraživanjima. On je visoko selektivni agonist δ-opioidnog receptora, koji proizvodi konvulzije u manjoj meri nego drugi lekovi iz ove familije.[3]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Holt, JD; Watson, MJ; Chang, JP; O'Neill, SJ; Wei, K; Pendergast, W; Gengo, PJ; Chang, KJ (2005). „DPI-221 4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats”. The Journal of pharmacology and experimental therapeutics 315 (2): 601–8. DOI:10.1124/jpet.105.090498. PMID 16020629.